Graft-vs-host disease: Difference between revisions

No edit summary
(gvh rf)
Line 1: Line 1:
==Background==
==Background==
*Acute vs Chronic
*Acute vs Chronic
**Acute: 1-12 weeks post graft
**Acute: 1-12 weeks post graft (<100 days)
**Chronic: >12 weeks
**Chronic: >12 weeks
*Transplanted graft with immunologically competent cells stimulated by host antigens and host is incapable of mounting an effective immunologic response
*Transplanted graft with immunologically competent cells stimulated by host antigens and host is incapable of mounting an effective immunologic response
*Occurs in leukemia/lymphoma or immunocompromised
*Occurs in leukemia/lymphoma or immunocompromised
**Most commonly post HSCT: Hematopoietic stem cell transplant
*Rare in solid organ transplant


==Clinical Features==
==Clinical Features==

Revision as of 04:21, 1 February 2016

Background

  • Acute vs Chronic
    • Acute: 1-12 weeks post graft (<100 days)
    • Chronic: >12 weeks
  • Transplanted graft with immunologically competent cells stimulated by host antigens and host is incapable of mounting an effective immunologic response
  • Occurs in leukemia/lymphoma or immunocompromised
    • Most commonly post HSCT: Hematopoietic stem cell transplant
  • Rare in solid organ transplant

Clinical Features

Differential Diagnosis

Transfusion Reaction Types

Diagnosis

  • LFT abnormalities
  • Pancytopenia

Management

  • Glucocorticoids

Disposition

See Also

External Links

References